All members of CR Medicon's expertise team are top experts in the industry. We have rich industry experience, from pre-clinical research to drug commercialization. Having supported many US and Chinese clients, we have the proven ability to accelerate clinical research and registration of innovative drugs in both markets. CR Medicon also organizes professional training sessions and conferences. By effective information exchange and interaction with medical colleagues, we work together to jointly contribute to the healthy growth of China's medical and pharmaceutical industry.
- Innovative drug Phase I-III clinical research and development strategy
- Innovative drug Phase I-III clinical trial operation and project management
- Data management and statistical analysis of clinical Phase I-IV studies
- Implementation experience of CDISC standards
- Pharmacovigilance system and its implementation
- ICH CTD and eCTD regulations and eCTD filing system implementation
- Regulatory pathway and strategy of innovative drug US-China dual registration